Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy ...

A novel DIPN method enhances GA segmentation by integrating ConvLSTM, projection attention, adaptive pooling, and contrastive ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

A cell-based subretinal implant shows promise in the treatment of geographic atrophy, achieving the unprecedented milestone ...

Bilco from Yarmouth Greyhound Rehoming faces daily battles due to a genetic disease called Progressive Retinal Atrophy (PRA).

Javed Shaikh, Director of RWE & HEOR, Axtria, explains how harnessing next-generation sequencing and AI-powered analytics ...